TECHNOLOGY
A new approach for personalizing treatments is currently in clinical trials : clinicians test potential therapies directly on patient-derived cells grown as 3D spheroids in the lab.
Okomera has developed a device for automating and miniaturizing ex vivo cancer testing in 3D, on a single microfluidic chip. Our technology allows for multiplexing >30 conditions on a single chip. Also co-cultures and/or T-cell interactions can be tested.
Interested in using our technology?
Contact us for more information!
Installation of Okomera’s automated liquid handler at Institut Pasteur. (January 2022)
ABOUT US
Okomera is a biotech start-up founded in Paris in 2020 by scientists from one of the world’s leading laboratories in droplet microfluidics and precision cancer medicine.
The Okomera technology was invented and patented by cofounders Raphaël Tomasi and Charles Baroud at École Polytechnique. We are currently collaborating with different KOLs to test patient samples within the context of European clinical trials.
OUR VISION
Our aim is to become the gold standard in functional precision medicine, having our device installed at cancer centers around the world. We want to improve patient’s outcomes, by screening the tumor biopsy for different treatments, finding the most efficient one for each and every patient.
PUBLICATIONS
Individual Control and Quantification of 3D Spheroids in a High-Density Microfluidic Droplet Array. Raphaël F.-X. Tomasi, Sébastien Sart, Tiphaine Champetier & Charles N. Baroud. Cell Reports Volume 31, Issue 8, 107670 (2020)
https://www.cell.com/cell-reports/fulltext/S2211-1247(20)30623-9
Mapping the structure and biological functions within mesenchymal bodies using microfluidics. Sébastien Sart, Raphaël F.-X. Tomasi, Antoine Barizien, Gabriel Amselem, Ana Cumano & Charles N. Baroud. Science Advances Volume 6, Article number: 10 (2020)
https://advances.sciencemag.org/content/6/10/eaaw7853
Multiscale cytometry and regulation of 3D cell cultures on a chip. Sébastien Sart, Raphaël F.-X. Tomasi, Gabriel Amselem & Charles N. Baroud. Nature Communications Volume 8, Article number: 469 (2017)
Contact Us
By clicking send, you accept that Okomera will use your contact information to send you relevant marketing messages. You can opt out of these communications at any time.
Our Office
iPEPS, The Healthtech Hub
Institut du Cerveau - Hôpital Pitié-Salpêtrière
47 boulevard de l'Hôpital - CS 2141475646
Paris CEDEX 13
FRANCE
